Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1978 1
1979 1
1980 2
1982 1
1983 1
1985 2
1986 1
1987 2
1991 1
1994 3
1995 1
1996 2
1997 2
2000 1
2001 2
2002 5
2003 2
2005 2
2007 6
2008 6
2009 8
2010 6
2011 7
2012 7
2013 9
2014 9
2015 13
2016 13
2017 14
2018 20
2019 38
2020 31
2021 43
2022 44
2023 49
2024 48
2025 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

395 results

Results by year

Filters applied: . Clear all
Page 1
Anxiety: Recognition and Treatment Options.
Vu V, Conant-Norville D. Vu V, et al. Psychiatr Clin North Am. 2021 Sep;44(3):373-380. doi: 10.1016/j.psc.2021.04.005. Epub 2021 Jun 16. Psychiatr Clin North Am. 2021. PMID: 34372994 Review.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Active eosinophils regulate host defence and immune responses in colitis.
Gurtner A, Borrelli C, Gonzalez-Perez I, Bach K, Acar IE, Núñez NG, Crepaz D, Handler K, Vu VP, Lafzi A, Stirm K, Raju D, Gschwend J, Basler K, Schneider C, Slack E, Valenta T, Becher B, Krebs P, Moor AE, Arnold IC. Gurtner A, et al. Among authors: vu vp. Nature. 2023 Mar;615(7950):151-157. doi: 10.1038/s41586-022-05628-7. Epub 2022 Dec 12. Nature. 2023. PMID: 36509106 Free PMC article.
HiBiT Cellular Thermal Shift Assay (HiBiT CETSA).
Ramachandran S, Szewczyk M, Barghout SH, Ciulli A, Barsyte-Lovejoy D, Vu V. Ramachandran S, et al. Among authors: vu v. Methods Mol Biol. 2023;2706:149-165. doi: 10.1007/978-1-0716-3397-7_11. Methods Mol Biol. 2023. PMID: 37558947
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Labrosse R, Chu JI, Armant MA, Everett JK, Pellin D, Kareddy N, Frelinger AL, Henderson LA, O'Connell AE, Biswas A, Coenen-van der Spek J, Miggelbrink A, Fiorini C, Adhikari H, Berry CC, Cantu VA, Fong J, Jaroslavsky J, Karadeniz DF, Li QZ, Reddy S, Roche AM, Zhu C, Whangbo JS, Dansereau C, Mackinnon B, Morris E, Koo SM, London WB, Baris S, Ozen A, Karakoc-Aydiner E, Despotovic JM, Forbes Satter LR, Saitoh A, Aizawa Y, King A, Nguyen MAT, Vu VDU, Snapper SB, Galy A, Notarangelo LD, Bushman FD, Williams DA, Pai SY. Labrosse R, et al. Among authors: vu vdu. Blood. 2023 Oct 12;142(15):1281-1296. doi: 10.1182/blood.2022019117. Blood. 2023. PMID: 37478401 Free PMC article.
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.
He J, Tsuboi M, Weder W, Chen KN, Hochmair MJ, Shih JY, Lee SY, Lee KY, Nhung NV, Saeteng S, Liu L, Xing L, Gia NH, Murakami S, Han Y, Saavedra MP, Yoon SH, Teixeira CHA, Escriu C, Martinez-Marti A, Blakely CM, Yatabe Y, Dacic S, Rukazenkov Y, Huang X, Dayal A, Chaft JE; NeoADAURA Investigators. He J, et al. J Clin Oncol. 2025 Sep 10;43(26):2875-2887. doi: 10.1200/JCO-25-00883. Epub 2025 Jun 2. J Clin Oncol. 2025. PMID: 40454705 Clinical Trial.
Starch-degrading polysaccharide monooxygenases.
Vu VV, Marletta MA. Vu VV, et al. Cell Mol Life Sci. 2016 Jul;73(14):2809-19. doi: 10.1007/s00018-016-2251-9. Epub 2016 May 12. Cell Mol Life Sci. 2016. PMID: 27170366 Free PMC article. Review.
Osteonecrosis Imaging.
Stroie OM, Vu VH. Stroie OM, et al. Among authors: vu vh. 2024 May 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 May 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 38861639 Free Books & Documents.
Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis.
Perez-Shibayama C, Gil-Cruz C, Cadosch N, Lütge M, Cheng HW, De Martin A, Frischmann K, Joachimbauer A, Onder L, Papadopoulou I, Papadopoulou C, Ring S, Krebs P, Vu VP, Nägele MP, Rossi VA, Parianos D, Zsilavecz VW, Cooper LT, Flammer A, Ruschitzka F, Rainer PP, Schmidt D, Ludewig B. Perez-Shibayama C, et al. Among authors: vu vp. Nat Cardiovasc Res. 2024 Mar;3(3):301-316. doi: 10.1038/s44161-024-00432-0. Epub 2024 Feb 19. Nat Cardiovasc Res. 2024. PMID: 39196111 Free PMC article.
395 results